Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Periodontitis in Menopausal Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients diagnosed as; periodontitis patients~* presence of a minimum of 6 teeth in the mouth~* at least 3 periodontal sites with probing pocket depth more or equal to 5mm~* women experiencing menopause for at least a year~Exclusion Criteria:~* women suffering from any systemic disorder that might affect the periodontal tissues such as; Diabetes Mellitus, immune disorders,..~* anemic patients~* smokers~* patients taking NSAIDs, supplements, antibiotics regularly used mouthwashes within the last 3 months~* participants in any other clinical trials

- Gender: FEMALE
- Minimum Age: 45 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- group 2 polyunsaturated fatty acids (Type: EXPERIMENTAL): intervention: systemic administration of 1000 mg polyunsaturated fatty acids. to be taken once daily with meals for 12 months~patients treated by scaling and root planing and oral systemic administration of Omega-3 fatty acids a soft gelatinous capsule containing 1000 mg polyunsaturated fatty acids (PUFAs)
- group 1 control (Type: SHAM_COMPARATOR): control group, patients treated by scaling and root planing and an oral soft gelatinous capsule containing olive oil to be taken once daily with meals for 12 months

Based on this trial design, predict the completion outcome and termination type (if applicable).